FindTrial
Sign In

To know the role of memory t cells in vitiligo

Analysis of Resident Memory T (TRM) cells and IL15 levels in vitiliginous patches as predictors of response to treatment and prognosis.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2020/01/022979
Enrollment
44
Registered
2020-01-27
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L80- Vitiligo

Interventions

Control Intervention1: not applicable: not applicable

Sponsors

IADVL Research grant
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. All new Non segmental vitiligo patients 2. Age above 18yrs

Exclusion criteria

Exclusion criteria: 1. Age below 18years 2. Segmental vitiligo patients 3. Non consented Patients 4. Pregnant and lactating women. 5. Patients with other autoimmune and immune deficiency (HIV etc) diseases. 6. Patients on any immunosuppressive drugs.

Design outcomes

Primary

MeasureTime frame
Identification of these markers in vitiligo patients may help in assessing the response to treatment and prognosis. Thus, we could be able to design highly effective and durable treatment strategy to these patientsTimepoint: 3 months—

Secondary

MeasureTime frame
Identification of these markers in vitiligo patients may help in assessing the response to treatment and prognosis. Thus, we could be able to design highly effective and durable treatment strategy to these patientsTimepoint: lifetime—

Countries

India

Contacts

Public ContactDr Vinutha Rangappa

JSS Medical college

drvinutharangappa@gmail.com09591077706

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026